









市场行情
/
股票
/
nasdaq-elv
/

Elevance Health Inc

ELV

346.980USD

+5.130+1.50%

收盘 01/29, 16:00（美东）报价延迟15分钟

77.11B总市值

13.76市盈率 TTM



Elevance Health Inc

346.980

+5.130+1.50%

概览公司财务分析

概览

公司

财务

分析

关于 Elevance Health Inc 公司

Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.

Elevance Health Inc简介



公司代码ELV

公司名称Elevance Health Inc

上市日期Oct 30, 2001

CEOBoudreaux (Gail K)

员工数量103158

证券类型Ordinary Share

年结日Oct 30

公司地址220 Virginia Avenue

城市INDIANAPOLIS

上市交易所NASDAQ OMX NASDAQ Basic NYSE

国家United States of America

邮编46204

电话18003311476

网址https://www.elevancehealth.com/

公司代码ELV

上市日期Oct 30, 2001

CEOBoudreaux (Gail K)

Elevance Health Inc公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Ramiro G. Peru

Independent Chairman of the Board

9.35K

+601.00%

Mr. Antonio F. Neri

Independent Director

4.92K

+601.00%

Dr. Bahija Jallal, Ph.D.

Independent Director

4.79K

+601.00%

Mr. Ronald W. Penczek

Chief Accounting Officer, Controller

1.69K

+65.00%

Ms. Deanna D. Strable-Soethout

Independent Director

1.65K

+601.00%

Mr. Steven H. (Steve) Collis, CPA

Independent Director

639.00

+639.00%

Mr. Robert L. Dixon, Jr.

Independent Director

Mr. Lewis (Lew) Hay, III

Independent Director

Mr. Peter D. (Pete) Haytaian

Executive Vice President and President, Carelon and CarelonRx

Mr. R. Kerry Clark

Independent Director

名称

名称/职务

职务

持股

持股变动

Mr. Ramiro G. Peru

Independent Chairman of the Board

9.35K

+601.00%

Mr. Antonio F. Neri

Independent Director

4.92K

+601.00%

Dr. Bahija Jallal, Ph.D.

Independent Director

4.79K

+601.00%

Mr. Ronald W. Penczek

Chief Accounting Officer, Controller

1.69K

+65.00%

Ms. Deanna D. Strable-Soethout

Independent Director

1.65K

+601.00%

Mr. Steven H. (Steve) Collis, CPA

Independent Director

639.00

+639.00%

收入明细

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

业务USD

名称

营收

占比

Premiums

41.79B

0.00%

Product revenue

6.16B

0.00%

Service fees

2.14B

0.00%

Reconciliation

624.00M

0.00%

Operating revenue - affliated

0.00

0.00%

由于公司未披露，未能获取相关数据

业务

地区

业务USD

名称

营收

占比

Premiums

41.79B

0.00%

Product revenue

6.16B

0.00%

Service fees

2.14B

0.00%

Reconciliation

624.00M

0.00%

Operating revenue - affliated

0.00

0.00%

股东统计

更新时间: 11月18日周二

持股股东

股东类型

持股股东

占比

The Vanguard Group, Inc.

10.30%

BlackRock Institutional Trust Company, N.A.

5.31%

State Street Investment Management (US)

4.66%

Wellington Management Company, LLP

2.98%

Sanders Capital, LLC

2.60%

其他

74.15%

持股股东

占比

The Vanguard Group, Inc.

10.30%

BlackRock Institutional Trust Company, N.A.

5.31%

State Street Investment Management (US)

4.66%

Wellington Management Company, LLP

2.98%

Sanders Capital, LLC

2.60%

其他

74.15%

股东类型

持股股东

占比

Investment Advisor

49.98%

Investment Advisor/Hedge Fund

30.92%

Pension Fund

2.77%

Bank and Trust

2.33%

Hedge Fund

2.17%

Research Firm

2.16%

Sovereign Wealth Fund

1.41%

Family Office

0.27%

Family Office

0.27%

其他

7.73%

机构持股



更新时间: 12月8日周一

报告期

机构数

持股数

持股占比

持股变动

2025Q4

3063

205.92M

97.95%

+22.74K

2025Q3

3138

205.95M

97.05%

-3.45M

2025Q2

3116

209.73M

96.68%

-566.57K

2025Q1

3115

208.90M

96.86%

-10.38M

2024Q4

3105

212.00M

93.76%

+298.05K

2024Q3

2993

212.22M

94.67%

-2.15M

2024Q2

2959

214.26M

94.25%

+1.04M

2024Q1

2925

213.00M

94.22%

-6.19M

2023Q4

2869

213.96M

93.90%

-1.80M

2023Q3

2746

215.71M

93.86%

-2.17M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

The Vanguard Group, Inc.

22.88M

10.3%

+133.40K

+0.59%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

11.81M

5.31%

+190.00K

+1.64%

Sep 30, 2025

State Street Investment Management (US)

10.35M

4.66%

-222.81K

-2.11%

Sep 30, 2025

Wellington Management Company, LLP

6.62M

2.98%

+303.10K

+4.80%

Sep 30, 2025

Sanders Capital, LLC

5.77M

2.6%

-56.29K

-0.97%

Sep 30, 2025

T. Rowe Price Associates, Inc.

5.50M

2.48%

-2.25M

-29.00%

Sep 30, 2025

Geode Capital Management, L.L.C.

5.14M

2.31%

+50.02K

+0.98%

Sep 30, 2025

Artisan Partners Limited Partnership

4.58M

2.06%

+901.63K

+24.53%

Sep 30, 2025

First Eagle Investment Management, L.L.C.

4.00M

1.8%

+798.46K

+24.95%

Sep 30, 2025

Harris Associates L.P.

3.19M

1.44%

+902.06K

+39.43%

Sep 30, 2025

持股ETF



更新时间: 12月6日周六

机构名称

占比

iShares U.S. Healthcare Providers ETF

4.43%

Monarch Dividend Plus Index ETF

3.25%

John Hancock Fundamental All Cap Core ETF

2.45%

GMO US Quality ETF

2.35%

VictoryShares Free Cash Flow ETF

2.32%

Bushido Capital US Equity ETF

2.2%

State Street SPDR S&P Health Care Services ETF

2.11%

First Eagle Global Equity ETF

2.03%

First Trust Total US Market AlphaDEX ETF

1.75%

First Trust Health Care Alphadex Fund

1.71%

iShares U.S. Healthcare Providers ETF

占比4.43%

Monarch Dividend Plus Index ETF

占比3.25%

John Hancock Fundamental All Cap Core ETF

占比2.45%

GMO US Quality ETF

占比2.35%

VictoryShares Free Cash Flow ETF

占比2.32%

Bushido Capital US Equity ETF

占比2.2%

State Street SPDR S&P Health Care Services ETF

占比2.11%

First Eagle Global Equity ETF

占比2.03%

First Trust Total US Market AlphaDEX ETF

占比1.75%

First Trust Health Care Alphadex Fund

占比1.71%

分红派息



近5年累计派现 5.24B 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

Oct 15, 2025

ELV.NB Final Cash Dividend of gross USD 1.71 paid on Dec 19, 2025 going ex on Dec 05, 2025

Dec 05, 2025

Dec 19, 2025

Dec 05, 2025

Jul 17, 2025

ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Sep 25, 2025 going ex on Sep 10, 2025

Sep 10, 2025

Sep 25, 2025

Sep 10, 2025

Apr 22, 2025

ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Jun 25, 2025 going ex on Jun 10, 2025

Jun 10, 2025

Jun 25, 2025

Jun 10, 2025

Jan 23, 2025

ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Mar 25, 2025 going ex on Mar 10, 2025

Mar 10, 2025

Mar 25, 2025

Mar 10, 2025

Oct 17, 2024

ELV.NB Final Cash Dividend of gross USD 1.63 paid on Dec 20, 2024 going ex on Dec 05, 2024

Dec 05, 2024

Dec 20, 2024

Dec 05, 2024

Jul 17, 2024

ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Sep 25, 2024 going ex on Sep 10, 2024

Sep 10, 2024

Sep 25, 2024

Sep 10, 2024

Apr 18, 2024

ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Jun 25, 2024 going ex on Jun 10, 2024

Jun 10, 2024

Jun 25, 2024

Jun 10, 2024

Jan 26, 2024

ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Mar 22, 2024 going ex on Mar 07, 2024

Mar 08, 2024

Mar 22, 2024

Mar 07, 2024

Oct 18, 2023

ELV.NB Final Cash Dividend of gross USD 1.48 paid on Dec 21, 2023 going ex on Dec 05, 2023

Dec 06, 2023

Dec 21, 2023

Dec 05, 2023

Jul 19, 2023

ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Sep 22, 2023 going ex on Sep 07, 2023

Sep 08, 2023

Sep 22, 2023

Sep 07, 2023

拆合股



公告日期

除权除息日

类型

比率

暂无数据

公告日期

除权除息日

类型

比率

暂无数据

KeyAI

